Mitral Valve Repair in Patients with Chronic Kidney Disease: Long-Term Outcomes and Cardiac Remodeling
Journal of Cardiothoracic and Vascular Anesthesia · 2025
DOI: 10.1053/j.jvca.2024.03.033 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2025. Verfasst von Jimmy J H Kang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Ventricular Remodeling, Mitral Valve Insufficiency, Mitral Valve. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Literature examining mitral valve repair (MVr) outcomes in patients with chronic kidney disease (CKD) is largely limited to short-term outcomes and percutaneous approaches. This study is the first to present long-term outcomes of mortality and morbidity with paired cardiac remodeling data from patients with CKD undergoing surgical MVr. DESIGN: A retrospective, observational, comparative study. SETTING: Single-center university hospital. PARTICIPANTS: Patients with varying stages of CKD undergoing MVr from 2004 to 2018. INTERVENTIONS: Patients were grouped by estimated glomerular filtration (eGFR) rate and followed for a maximum of 15 years. Long-term outcomes and measures of cardiac remodeling were then compared between the groups. MEASUREMENTS AND MAIN RESULTS: The primary outcome was all-cause mortality. Secondary outcomes included measures of postoperative morbidity and cardiac remodeling. Every 10-unit increase in eGFR was associated with a significant reduction in all-cause mortality at 5 years (hazard ratio [HR]: 0.81, 95% confidence interval [CI]: 0.67-0.98, p = 0.028), 10 years (HR: 0.82, 95% CI: 0.72-0.94, p = 0.004), and at 15 years (HR: 0.78, 95% CI: 0.69-0.88, p < 0.001). The moderate CKD group had significantly higher rates of all-cause mortality at 15 years (HR: 3.38, 95% CI: 1.28-8.98, p = 0.014). eGFR was a significant predictor for residual moderate-to-severe mitral regurgitation at 1 year (HR: 0.74, 95% CI: 0.57-0.96, p = 0.024). There was positive cardiac remodeling following MVr in patients with CKD with a significant reduction in left ventricular size and left atrium volume. CONCLUSIONS: In patients with CKD undergoing MVr, eGFR is a predictor of decreased long-term survival and residual mitral regurgitation at 1 year. Further investigation is required to optimize postoperative outcomes in this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
- Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Department of Anesthesia, University of Alberta, Edmonton, Alberta, Canada.
- Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada. Electronic address: jeevan@ualberta.ca.
Zitieren
APA
Kang, J. J. H., Bozso, S. J., El-Andari, R., Fialka, N. M., Hassanabad, M. F., Boe, D., Hong, Y., Moon, M. C., Freed, D. H., Nagendran, J., & Nagendran, J. (2025). Mitral Valve Repair in Patients with Chronic Kidney Disease: Long-Term Outcomes and Cardiac Remodeling. Journal of Cardiothoracic and Vascular Anesthesia. https://doi.org/10.1053/j.jvca.2024.03.033
Vancouver
Kang JJH, Bozso SJ, El-Andari R, Fialka NM, Hassanabad MF, Boe D, et al. Mitral Valve Repair in Patients with Chronic Kidney Disease: Long-Term Outcomes and Cardiac Remodeling. Journal of Cardiothoracic and Vascular Anesthesia. 2025. doi:10.1053/j.jvca.2024.03.033
BibTeX
@article{Kang2025,
author = {Kang, Jimmy J H and Bozso, Sabin J and El-Andari, Ryaan and Fialka, Nicholas M and Hassanabad, Mortaza F and Boe, Dana and Hong, Yongzhe and Moon, Michael C and Freed, Darren H and Nagendran, Jayan and Nagendran, Jeevan},
title = {Mitral Valve Repair in Patients with Chronic Kidney Disease: Long-Term Outcomes and Cardiac Remodeling},
journal = {Journal of Cardiothoracic and Vascular Anesthesia},
year = {2025},
doi = {10.1053/j.jvca.2024.03.033}
}
EUVIMED